GlucoTrack (NASDAQ:GCTK) Stock Price Down 2.2% – Here’s What Happened

Posted by Defense World Staff on Dec 24th, 2025

Shares of GlucoTrack, Inc. (NASDAQ:GCTK – Get Free Report) were down 2.2% on Tuesday . The stock traded as low as $4.45 and last traded at $4.50. Approximately 10,583 shares were traded during mid-day trading, a decline of 85% from the average daily volume of 69,123 shares. The stock had previously closed at $4.60.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GlucoTrack in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Read Our Latest Stock Analysis on GlucoTrack

GlucoTrack Trading Down 2.2%

The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $4.10 million, a price-to-earnings ratio of -0.13 and a beta of 0.30. The business has a 50 day simple moving average of $5.83 and a 200-day simple moving average of $6.14.

Institutional Investors Weigh In On GlucoTrack

A hedge fund recently raised its stake in GlucoTrack stock. Bank of America Corp DE boosted its stake in shares of GlucoTrack, Inc. (NASDAQ:GCTK – Free Report) by 102,125.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,089 shares of the company’s stock after purchasing an additional 4,085 shares during the period. Bank of America Corp DE owned approximately 0.85% of GlucoTrack worth $25,000 at the end of the most recent reporting period. 10.92% of the stock is owned by institutional investors and hedge funds.

About GlucoTrack

(Get Free Report)

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.